Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]

A. A. Ashrani, D. A. Gabriel, J. L. Gajewski, D. R. Jacobs, D. J. Weisdorf, N. S. Key

    Research output: Contribution to journalLetterpeer-review

    14 Scopus citations

    Fingerprint

    Dive into the research topics of 'Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]'. Together they form a unique fingerprint.